• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板活化因子(PAF-乙醚):与肾上腺素在人血小板上的不依赖血栓素的协同作用及其作用模式的最新见解

Platelet-activating factor (PAF-acether): thromboxane-independent synergism with adrenaline on human platelets and recent insights into its mode of action.

作者信息

Fouque F, Joseph D, Vargaftig B B

出版信息

Agents Actions. 1982 Dec;12(5-6):720-2. doi: 10.1007/BF01965091.

DOI:10.1007/BF01965091
PMID:7164947
Abstract

The mode of action of PAF-acether on human and rabbit plasma-free platelets is reviewed. PAF-acether and adrenaline synergize to trigger aggregation of human platelets, and this synergism is refractory to aspirin. When degranulated rabbit platelets are stimulated with PAF-acether, with thrombin or with the snake venom component convulxin, aggregation is obtained in the absence of detectable secretion. Collagen-induced aggregation is reduced, and is suppressed when aspirin is applied to the degranulated platelets. The formation of PAF-acether by platelets, and their stimulation by PAF-acether itself, should be added to the newly recognized pathways for platelet stimulation.

摘要

本文综述了血小板活化因子(PAF-乙醚)对人和兔无血浆血小板的作用方式。PAF-乙醚与肾上腺素协同作用,触发人血小板聚集,且这种协同作用不受阿司匹林影响。当用PAF-乙醚、凝血酶或蛇毒成分convulxin刺激脱颗粒的兔血小板时,在未检测到分泌的情况下即可发生聚集。胶原蛋白诱导的聚集减少,当对脱颗粒血小板应用阿司匹林时,聚集受到抑制。血小板PAF-乙醚的形成及其自身受PAF-乙醚的刺激,应添加到新认识的血小板刺激途径中。

相似文献

1
Platelet-activating factor (PAF-acether): thromboxane-independent synergism with adrenaline on human platelets and recent insights into its mode of action.血小板活化因子(PAF-乙醚):与肾上腺素在人血小板上的不依赖血栓素的协同作用及其作用模式的最新见解
Agents Actions. 1982 Dec;12(5-6):720-2. doi: 10.1007/BF01965091.
2
Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.血小板激活因子和肾上腺素引发的不依赖环氧化酶的血小板聚集
Br J Pharmacol. 1984 Nov;83(3):625-33. doi: 10.1111/j.1476-5381.1984.tb16216.x.
3
Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets.
Thromb Res. 1982 Nov 15;28(4):557-73. doi: 10.1016/0049-3848(82)90171-2.
4
Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.用血小板活化因子(PAF-乙酰醚)使兔血小板脱颗粒:一种揭示血小板活化物质作用方式的新方法。
Thromb Haemost. 1982 Aug 24;48(1):67-71.
5
PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin.血小板活化因子可能并不介导血小板聚集的第三条途径,因为自身脱敏作用会降低低凝血酶的效应,但会增强芋螺毒素的效应。
Thromb Haemost. 1985 Feb 18;53(1):99-104.
6
Potentiation and inhibition by clonidine of PAF-acether-induced human platelet activation.
Eur J Pharmacol. 1987 Mar 17;135(2):211-8. doi: 10.1016/0014-2999(87)90613-3.
7
Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets.血小板活化因子拮抗剂不能抑制凝血酶诱导的、经二磷酸腺苷去除及阿司匹林处理的人血小板聚集。
Agents Actions. 1987 Jun;21(1-2):195-202. doi: 10.1007/BF01974942.
8
Synergized activation of human platelets by epinephrine and platelet-activating factor-acether is adenosine diphosphate and thromboxane A2-independent.
Adv Prostaglandin Thromboxane Leukot Res. 1983;11:429-33.
9
Adrenaline/PAF acether synergism on human platelets: involvement of Hydergine.肾上腺素/血小板活化因子对人血小板的协同作用:氢化麦角碱的影响
J Pharmacol. 1985;16 Suppl 3:129-34.
10
Dissociation between inhibition of phospholipid methylation and production of PAF-acether by rabbit platelets.兔血小板中磷脂甲基化抑制与血小板活化因子-乙醚生成之间的解离。
Experientia. 1984 Apr 15;40(4):374-7. doi: 10.1007/BF01952560.

引用本文的文献

1
Protective Effect of Olive Oil Microconstituents in Atherosclerosis: Emphasis on PAF Implicated Atherosclerosis Theory.橄榄油微成分在动脉粥样硬化中的保护作用:强调与 PAF 相关的动脉粥样硬化理论。
Biomolecules. 2023 Apr 20;13(4):700. doi: 10.3390/biom13040700.
2
Pathophysiological mechanisms of sudden death induced by platelet activating factor.血小板活化因子所致猝死的病理生理机制
Br J Pharmacol. 1984 Sep;83(1):125-30. doi: 10.1111/j.1476-5381.1984.tb10126.x.

本文引用的文献

1
Adrenaline-induced reactions of human platelets in hirudin plasma.人血小板在水蛭素血浆中肾上腺素诱导的反应
Haemostasis. 1980;9(3):188-92. doi: 10.1159/000214357.
2
Human platelet stimulation by acetyl glyceryl ether phosphorylcholine.乙酰甘油醚磷酸胆碱对人血小板的刺激作用。
J Clin Invest. 1981 Mar;67(3):903-6. doi: 10.1172/jci110108.
3
Present concepts on the mechanisms of platelet aggregation.当前关于血小板聚集机制的概念。
Biochem Pharmacol. 1981 Feb 15;30(4):263-71. doi: 10.1016/0006-2952(81)90052-6.
4
Biosynthesis of platelet-activating factor (PAF-ACETHER). II. Involvement of phospholipase A2 in the formation of PAF-ACETHER and lyso-PAF-ACETHER from rabbit platelets.血小板激活因子(PAF-乙酰醚)的生物合成。II. 磷脂酶A2参与兔血小板中PAF-乙酰醚和溶血PAF-乙酰醚的形成。
Thromb Res. 1982 Mar 1;25(5):375-85. doi: 10.1016/0049-3848(82)90128-1.
5
Dissociation of platelet activation from transmethylation of their membrane phospholipids.
Nature. 1981 Oct 22;293(5834):660-2. doi: 10.1038/293660a0.
6
Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.血小板中血小板活化因子(PAF - 乙酰醚)的分泌:聚集剂的作用
Br J Haematol. 1980 Nov;46(3):455-64. doi: 10.1111/j.1365-2141.1980.tb05993.x.
7
Effects of acetyl glyceryl ether phosphorylcholine on human platelet function in vitro.
Blood. 1981 Nov;58(5):1027-31.
8
Interference of bromophenacyl bromide with platelet phospholipase A2 activity induced by thrombin and by the ionophore A23187.溴苯酰溴对凝血酶和离子载体A23187诱导的血小板磷脂酶A2活性的干扰。
Thromb Res. 1980;17(1-2):91-102. doi: 10.1016/0049-3848(80)90297-2.
9
In vitro and in vivo functions of thrombin-treated platelets.凝血酶处理的血小板的体外和体内功能
Thromb Haemost. 1976 Feb 29;35(1):151-66.
10
The role of platelet-activating factor in platelet aggregation.血小板活化因子在血小板聚集过程中的作用。
Nature. 1979 Jun 28;279(5716):799-800. doi: 10.1038/279799a0.